Abstract
Platelets are rich sources of growth factors and enzymes that are implicated in a number of diseases including obesity, atherosclerosis, heart disease, syndrome X, liver and kidney diseases and certain types of cancers. In this research we investigated, if platelets in Zucker obese rats differ from their lean counterparts with respect to the levels of TGF-β and COX isoforms, implicated in the pathogenesis of chronic diseases. In addition, we investigated if energy intake of the animals affects the platelet physiology. Platelets were isolated from obese and lean rats bearing preneoplastic lesions in their colon. Prior to platelet isolation these rats were fed either ad libitum (Ob or Ln) or energy restricted (Ob-ER or Ln-ER) diets for 8 weeks (n = 8/group). The levels of TGF-β1/-β2 and COX-1/-2 proteins in platelets were analyzed by Western blot. The platelets of the Ob rats had significantly higher levels of TGF-β1, COX-1/-2 (p < 0.001) than did the platelets of the Ln rats and were not affected by moderate energy restriction. There were no significant differences in the protein expression of platelet TGF-β2 among any of the groups. These results demonstrate that cytokines and candidates playing a role in the pathogenesis of chronic diseases, such as TGF-β1 and COX-1/-2, are over-expressed in platelets of Zucker obese rats by comparison to their lean counterparts. These findings also demonstrate that the genotype of the animals exerts a significant effect on the biochemical composition of the platelets and could contribute to the pathogenesis of colon cancer and other metabolic abnormalities associated with obesity.
References
Kushner RF: Medical management of obesity, Semin Gastrointest Dis 13(3): 123–132, 2002
Valettas N, Herrmann HC: The role of platelets and platelet inhibition in acute myocardial infarction. Coronary Art Dis 14: 357–363, 2003
Huo Y, Ley KF: Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 14: 18–22, 2004
Danese S, Motte Cd Cde L, Fiocchi C: Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 99: 938–945, 2004
Sierko E, Wojtukiewicz MZ: Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30: 95–108, 2004
Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT: Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91: 4–15, 2004
Raju J, Bird RP: Differential modulation of transforming growth factor-βs and cyclooxygenases in the platelet lysates of male F344 rats by dietary lipids and piroxicam. Mol Cell Biochem 231: 139–146, 2002
Adam JM, Raju J, Khalil N, Bird RP: Evidence for the involvement of dietary lipids on the modulation of transforming growth factor-beta1 in the platelets of male rats. Mol Cell Biochem 211: 145–152, 2000
Raju J, Bird RP: Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic TGF-β and COX isoforms in Zucker obese (fa/fa) rats. Cancer Res 63: 6595–6601, 2003
Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ: Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152: 847–854, 2000
Ford ES: Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol 150: 390–398, 1999
Weber RV, Stein DE, Scholes J, Kral JG: Obesity potentiates AOM-induced colon cancer. Dig Dis Sci 45(5): 890–895, 2000
Fain JN, Ballou LR, Bahouth SW: Obesity is induced in mice heterozygous for cyclooxygenase-2. Prostaglandins Other Lipid Mediat 65: 199–209, 2001
Samad F, Yamamoto K, Pandey M, Loskutoff DJ: Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med 3: 37–48, 1997
American Institute of Nutrition, Report of the ad hoc committee on standards for nutrition studies. J Nutr 123: 1939–1951, 1993
Lasko CM, Bird RP: Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention. Cancer Epidemiol Biomarkers Prev 4: 49–55, 1995
Heemskerk JW, Feijge MA, Kalfusz R, Hornstra G: Influence of dietary fatty acids on membrane fluidity and activation of rat platelets. Biochim Biophys Acta 1004: 252–260, 1989
McCaleb ML, Sredy J: Metabolic abnormalities of the hyperglycemic obese Zucker rat. Metabolism 41: 522–525, 1992
Bray GA: The Zucker-fatty rat: a review, Fed Proc 36(2): 148–153, 1977
Liu RH, Mizuta M, Kurose T, Matsukura S: Early events involved in the development of insulin resistance in Zucker fatty rat. Int J Obes Relat Metab Disord. 26(3): 318–326, 2002
Nash GF, Turner LF, Scully MF, Kakkar AK: Platelets and cancer. Lancet Oncol 3: 425–430, 2002
Verheul HM, Pinedo HM: The importance of platelet counts and their contents in cancer. Clin Cancer Res 9: 3219–3221, 2003
Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM: Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3: 2187–2190, 1997
Salven P, Orpana A, Joensuu H: Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 5: 487–491, 1999
Belloc C, Lu H, Soria C, Fridman R, Legrand Y, Menashi S: The effect of platelets on invasiveness and protease production of human mammary tumor cells. Int J Cancer 60: 413–417, 1995
Kim YJ, Borsig L, Han HL, Varki NM, Varki A: Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 155: 461–472, 1999
Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353–364, 1996
Raju J, McCarthy B, Bird RP: Steady state levels of transforming growth factor-β1 and -β2 mRNA and protein expression are elevated in colonic tumors in vivo irrespective of dietary lipids intervention. Int J Cancer 100: 635–641, 2002
Bird RP, Good CK: The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112–113: 395–402, 2000
Govinden R, Bhoola KD: Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther 98: 257–265, 2003
DuBois RN: Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res 37: 124–137, 2003
Alessi MC, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, Juhan-Vague I: Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49: 1374–1380, 2000
Landgraf-Leurs MM, Loy A, Christea C, Weber PC, Siess W, Herberg} LL, Landgraf R: Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats. Prostaglandins 22: 521–536, 1981
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raju, J., Bajaj, G., Chrusch, J. et al. Obese state leads to elevated levels of TGF-β and COX isoforms in platelets of Zucker rats. Mol Cell Biochem 284, 19–24 (2006). https://doi.org/10.1007/s11010-005-9008-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-9008-3